Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes
NCT04324229Completed
- Sponsor
- Turku University Hospital
- Start
- Feb 2020
- Primary completion
- Apr 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Liraglutide 1.8 mg with Placebo (2 arms). Primary endpoint: Incidence of type 2 diabetes at 5 years. Started Feb 2020; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04324229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04324229.